Resmed Inc
(RMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 194,476 | 276,149 | 295,278 | 230,635 | 255,865 |
| Receivables | 526,036 | 575,554 | 614,292 | 525,014 | 509,364 |
| Inventories | 592,146 | 506,644 | 457,033 | 484,061 | 474,821 |
| TOTAL | $1,547,240 | $1,586,255 | $1,574,757 | $1,466,150 | $1,451,485 |
| Non-Current Assets | |||||
| PPE Net | 477,778 | 467,344 | 463,490 | 455,106 | 459,472 |
| Intangibles | 2,323,472 | 2,297,437 | 2,320,483 | 2,335,550 | 2,323,490 |
| Other Non-Current Assets | 386,252 | 378,131 | 369,395 | 328,918 | 338,409 |
| TOTAL | $3,187,502 | $3,142,912 | $3,153,368 | $3,119,574 | $3,121,371 |
| Total Assets | $4,734,742 | $4,729,167 | $4,728,125 | $4,585,724 | $4,572,856 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 163,369 | 173,696 | 138,008 | 117,222 | 122,166 |
| Accrued Expenses | 286,803 | 274,106 | 320,599 | 304,693 | 280,332 |
| TOTAL | $621,064 | $624,158 | $911,766 | $876,541 | $577,335 |
| Non-Current Liabilities | |||||
| Long Term Debt | 667,979 | 793,668 | 643,351 | 719,046 | 813,732 |
| Deferred Revenues | 111,647 | 112,528 | 109,611 | 105,342 | 105,238 |
| Other Non-Current Liabilities | 192,564 | 180,743 | 184,514 | 181,531 | 217,173 |
| TOTAL | $967,843 | $1,078,960 | $930,680 | $999,949 | $1,130,537 |
| Total Liabilities | $1,588,907 | $1,703,118 | $1,842,446 | $1,876,490 | $1,707,872 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 146,234 | 145,723 | 145,681 | 145,518 | 145,509 |
| Common Shares | 585 | 583 | 583 | 582 | 582 |
| Retained earnings | 3,362,570 | 3,222,064 | 3,079,640 | 2,941,336 | 3,076,569 |
| Other shareholders' equity | -223,351 | -217,259 | -193,743 | -196,229 | -163,407 |
| TOTAL | $3,145,835 | $3,026,049 | $2,885,679 | $2,709,234 | $2,864,984 |
| Total Liabilities And Equity | $4,734,742 | $4,729,167 | $4,728,125 | $4,585,724 | $4,572,856 |